B2BROKER
19.1.2021 11:02:47 CET | Business Wire | Press release
B2Broker , a liquidity and technology provider of solutions for the crypto and Forex industry, has added a new range of features to its matching engine, B2Trader, enabling client demands to be met in record time.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005197/en/
About B2Trader
B2Trader is used by many of the world's best-known exchanges, MTF Brokers, Security Exchanges, Market Makers, Spot FX Brokers and EMIs, with the job of matching an incoming market order of the user with the existing limit order of another user. The engine works 24/7 in parallel with the round-the-clock rhythm of the crypto markets without any breaks.
Matching - Tech Stack, Details, Scheme of the Module and Capacity
The order matcher is designed for crypto trading and low-latency automatic trading systems and is able to fulfill 10,000 requests per second with an average latency of 500 ms. The new matching engine uses C # ASP.NET Core programming languages for the back-end and includes a trading mechanism for matching orders, various APIs and synchronization services and databases.
API - All Details, Languages and Capacity
The stability and performance aspects of the engine now allow for the development of faster APIs. B2Broker has introduced a new API for robotic trading and public data access which handles trading and public requests much faster while positively affecting the overall system performance (trading and public API - Websocket/Rest). With new API access, users can connect directly into the matching system and operate ultra-fast trading orders or receive crypto markets data on DOMs.
Security
B2Trader incorporates a series of the latest features to provide the best possible protection from technical and fraud threats. These include an anti-throttling system, anti-spoofing protection and DDoS protection. Other security features include 2FA, adding an extra layer of security, and an IP Whitelist which puts in place a restriction to work only under a certain IP inside the admin panel.
Front End
A professional GUI meets all requirements from beginners to pro-traders. It provides a multitude of features and a high degree of customisation including adaptive colouring, easy and highly responsive navigation menu, grouping for sorting options into a more convenient structure and a customisable Dynamic User Interface with colour and font customisation which includes easy addition of widgets, workspaces for various trading styles, widgets customization and workspace arrangement.
Some recent developments include a watchlist that allows for the addition of favourite instruments to monitor percentage changes, White/Night mode, a broad variety of deposit/withdrawal methods featuring B2BinPay , IOC/FOK order settings and the availability of multiple sources of liquidity available for connection with B2Trader.
Back Office
B2Trader admin takes care of all operational options that need to be carried out by the exchange daily, delivering them in a user-friendly and sophisticated manner. The admin module allows you to manage and set up and change exchange user trading/withdrawal permissions, extract information on the history of user logins to the exchange UI, transfer history, user asset balances, information on a user's aggregate balance in indicative currency, setup commissions for the markets or particular user and more, with safety always a top priority.
SAAS AWS
B2Trader uses hosting solutions that dynamically scale resources and support the most demanding and highly loaded projects. AWS hosting offers high levels of availability, scalability and performance, requiring higher amounts of management and administration that is fully organised by B2Broker.
Third-Party Integrations
To set up and run a successful exchange business, there needs to be an equal focus on sales and marketing, compliance, deposits, withdrawals, licenses, and the regulatory framework, etc. To this end, B2Broker has integrated a variety of services that help exchanges manage all aspects effectively. These include B2BinPay, B2Core , Crystal Blockchain, Leading Fiat PSPs, SumSub, B2BX and MarksMan.
The latest features combined with external integrations further enhance B2Trader to deliver a matching engine with the ultimate in performance and functionality, while ensuring that all market participants are given the best execution.
New clients can now benefit from a discount on setup, offering more favourable pricing than 2020 due to COVID and the new market bull run.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210119005197/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press release
Autonomous launch, recovery, and recharge from military vehicles and fixed installations; Three-drone rotation provides persistent surveillance and real-time targeting data in contested environments Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integrati
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom